Latest news & insights
Boyds strengthens expertise with key appointment of Susan Tansey
Boyds is delighted to welcome Susan Tansey who joins the business as Consultant Pharmaceutical Physician. Dr Tansey joins Boyds with more than 20 years’ experience
Boyds acquires Blue Duck Consultancy Ltd
Boyds has enhanced its clinical and medical affairs services offering following the acquisition of Blue Duck Consulting. Since 2013, Blue Duck has provided expert preclinical
Boyds reports record-breaking growth 12 months on from Queen’s Award
Boyds has reported record-breaking growth in its overseas turnover in the 12 months since it was recognised with one of the UK’s most prestigious awards,
Boyds bolsters Regulatory Affairs team with appointment of Claire Scruton
Boyds has announced a key appointment in support of its continuing growth plans, welcoming Claire Scruton as Senior Manager of CMC Regulatory Affairs. At Boyds,
American Society of Gene and Cell Therapy Annual Meeting, Washington
Professor Alan Boyd will be chairing the Audentes Symposium session at the American Society of Gene and Cell Therapy (ASGCT) annual meeting in Washington on
Boyds strengthens Regulatory team with appointment of Sabine Rühle
Boyds has announced a key appointment in support of its continued growth plans, welcoming Dr Sabine Rühle as Senior Associate of Regulatory Affairs. A member of
Boyds builds on growth plans with clinical operations hire
Boyds has further strengthened its clinical operations offering with the appointment of Pippa Bjaaland as a Senior Clinical Research Associate (CRA), as part of an
New Dublin office in Ireland for Boyds
Boyds has opened an office in Dublin, Ireland in a step that will ensure the continuity of service to its clients once the UK leaves
